NMG
RMD icon

New Millennium Group’s ResMed RMD Stock Holding History

New Millennium Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$16.9K Hold
70
– – 0.01% 178
2025
Q3 		$19.2K Buy
+70
New +$19.1K 0.01% 179
2025
Q1 		– Sell
-6
Closed -$1.37K – 600
2024
Q4 		$1.37K Buy
+6
New +$1.45K ﹤0.01% 418

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

New Millennium Group's RMD Position: Q4 2025 in Review

New Millennium Group held its ResMed (RMD) position steady in Q4 2025 at 70 shares worth $16.9K. The position accounts for 0.01% of the portfolio, ranked #178.

New Millennium Group first reported a position in RMD in Q4 2024 and has held it in 3 quarters since. The position peaked at $19.2K in Q3 2025. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • New Millennium Group held 70 shares of ResMed worth $16.9K as of Q4 2025.
  • New Millennium Group left its ResMed share count unchanged in Q4 2025.
  • ResMed made up 0.01% of New Millennium Group's portfolio in Q4 2025, its #178 holding.
  • New Millennium Group first reported a position in ResMed in Q4 2024 and has held it in 3 quarters since.
  • New Millennium Group's ResMed position peaked at $19.2K in Q3 2025.
  • 945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.